key: cord-0840134-l7iovqmg authors: Son, Mi Ju; Jung, Jeeyoun; Kim, Young‐Eun; Yeum, Chang‐Sub; Lee, So Min; Jung, So Young; Kwon, Ojin; Kim, Sungha; Kang, Jeong‐In; Kim, Hye‐Lin; Lee, Jung‐Eun; Lee, Dong‐Hyo title: Treating nasal symptoms associated with rhinitis using the intranasal herbal ointment Biyeom‐go: A prospective observational study date: 2019-10-29 journal: Clin Otolaryngol DOI: 10.1111/coa.13425 sha: d89b71dc9725043b0a554e5b55791ef59e51d05a doc_id: 840134 cord_uid: l7iovqmg OBJECTIVES: The aim of the current study was to investigate the effectiveness and clinical feasibility of Biyeom‐go for the treatment of nasal symptoms associated with rhinitis. DESIGN: Prospective observational study. SETTING: This study was conducted at the Woosuk Korean Medicine Medical Center in South Korea. PARTICIPANTS: Fifty‐eight patients with rhinitis participated in this study. All patients received Biyeom‐go treatment >3 times daily for a total of 4 weeks. MAIN OUTCOME MEASURES: The primary outcome was the total nasal symptom score. Mini‐rhinoconjunctivitis quality of life questionnaire, nasal endoscopy index, total serum immunoglobulin E levels and immunologic factors in nasal lavage fluid were also measured. RESULTS: Biyeom‐go administration was associated with significant improvements in total nasal symptoms scores (P < .0001) and mini‐rhinoconjunctivitis quality of life questionnaire scores (P < .0001) in a time‐dependent manner. The nasal endoscopy index also significantly improved at weeks 2 (P = .0049), 3 (P < .0001) and 4 (P = .0001) after Biyeom‐go treatment. Significantly, increased interleukin‐2 levels (P = .005) and decreased interleukin‐8, chemokine (C‐C motif) ligand (CCL) 5, chemokine (C‐X‐C motif) ligand (CXCL) 9, CCL2 and CXCL10 levels were observed in the nasal lavage fluid. CONCLUSIONS: The present findings suggest that Biyeom‐go may be beneficial for the management of rhinitis symptoms and rhinitis‐associated quality of life. Further well‐designed randomised controlled trials are needed to evaluate the effectiveness of Biyeom‐go for rhinitis. Rhinitisisacommonconditionthataffectsapproximately20%-25% ofthepopulation. 1 Symptomsofrhinitisareoftenignoredbecause they are frequently associated with common cold or disappear spontaneously.However,rhinitiscandisruptsleepandhasanegativeimpactondailyfunctionandperformance 2 ;itcanalsoleadto rhinosinusitis, asthma, otitis media and learning impairment. 3 The economic burden of rhinitis is estimated to be approximately 657 USDperpatienteachyearintheUnitedStates, 4 andtotalhealthcare expenditureassociatedwithallergicrhinitisis272.92millionUSDin theKoreanpopulation. 5 Intranasal herbal therapies, including ointments, drops and sprays, are widely used for treating rhinitis in East Asian countries. 6, 7 Biyeom-go is an herbal ointment that is clinically used in Korean Medicine to improve nasal symptoms associated with rhinitis. Biyeom-go is prepared by the addition of Sophorae Radix and Glycyrrhizae Radix et Rhizoma to the Korean Medicine herbal prescription, Hwanglyeonhaedok-tang (HHT), which consists of Coptidis Rhizoma, Cortex Phellodendri, Scutellariae Radix and GardeniaeFructus. 8, 9 ExperimentalstudieshavesuggestedthatHHThasanti-inflammatory effects by regulating inflammation-related cytokines, includingnitricoxide,prostaglandinE 2 ,interleukin(IL)-6andtumour necrosisfactor(TNF)-α, 10-12 andanti-allergiceffectsbysuppressing eosinophil and histamines. 13, 14 Biyeom-go, which is derived from HHT, is assumed to reduce various symptoms caused by nasal inflammation, including nasal congestion, rhinorrhea and sneezing, butitssafetyandeffectivenessinhumanshavenotbeenthoroughly investigated. The aim of the current study was to investigate the safety, effectiveness and clinical feasibility of Biyeom-go for the treatmentofnasalsymptomsassociatedwithrhinitis. Thetime-pointsatwhichoutcomesweremeasuredaredetailedinTable S1.TheprimaryoutcomewasTNSS.Mini-rhinoconjunctivitisqualityof lifequestionnaire(RQLQ),nasalendoscopyindex,totalserumimmu-noglobulinE(IgE)levelsandimmunologicfactorsderivedfromnasal lavagefluid(NLF)werealsoexamined.TNSSandmini-RQLQwereassessedateveryvisit(atotalof5times).Thenasalcavitywasassessed • Thisprospective,observationalstudyevaluatedtheef-fectivenessandclinicalfeasibilityofBiyeom-goforthe treatmentofnasalsymptomsassociatedwithrhinitis. • Biyeom-go treatment gradually improved total nasal symptomscoresandmini-rhinoconjunctivitisqualityof lifequestionnairescoresinrhinitispatients. • IL-2levelssignificantlyincreasedandIL-8,CCL5,CXCL9, CCL2 and CXCL10 levels were significantly reduced in thenasallavagefluidafterBiyeom-gotreatment. • No serious adverse effects or complications were observed. usingthenasalendoscopyindexateveryvisit. 15 Photographsofthe anterior nasal cavity were obtained using a KAU-3000 HARMONY ENTmachine(KASAMAENTCo.,Ltd.).Aftercompletionofthestudy, allphotographswereindependentlyscoredbasedonnasalendoscopy index assessment guidelines 15 Forthesafetyofthestudy,thevitalsignsofparticipantswereexamined at every visit. Information about adverse events (AEs) was providedtoallparticipants.AnyAEspotentiallyrelatedtoBiyeomgowereexamined,andanyassociatedmeasurementsandoutcomes wereassessed. FromDecember2016toMarch2017,60patientswereenrolledin the study. Two subsequently dropped out prior to Biyeom-go administration,andtwodroppedoutjustbeforetheend-pointexamination.Atotalof56patientscompletedthestudy,and58patients were analysed after missing data were imputed for the 2 patients whodroppedoutjustbeforetheend-pointexamination. Patient characteristics are summarised in Table 1 AsBiyeom-gotreatmentprogressed,meanmini-RQLQscoresexhibited significant improvements compared with baseline ( Figure 2A ). Ofthe58patients,14reportedthefollowingAEs:commoncold (6) *P<.05, **P<.01, ***P < .001 and ****P < .0001 groupisessentialtoassesstheeffects.Therefore,futurerandomised controlledtrialsareneededtoconfirmtheeffectsofBiyeom-go. The participants included in the present study were treated with Biyeom-go alone to evaluate its clinical effects in rhinitis patients. Considering its efficacy in terms of improvements in TNSSs, mini-RQLQscores,nasalendoscopyindexandimmunebiomarkerlevels, aswellasacompleteabsenceofseriousAEs,inpatientswithrhinitis; Biyeom-go treatment is feasible for clinical practice and is a safe option for the treatment of rhinitis. This study is the first to examinetheclinicaleffectivenessofBiyeom-go.Ourfindingssuggest that intranasal Biyeom-go administration is safe, and a largescalecontrolledclinicaltrialiswarrantedtodeterminetheefficacy ofBiyeom-goforthemanagementofrhinitissymptoms. Theauthorsdeclarenoconflictsofinterest. The datasets analysed during the current study are available from thecorrespondingauthoruponreasonablerequest. Mi Ju Son https://orcid.org/0000-0003-1701-9122 Jeeyoun Jung https://orcid.org/0000-0002-9213-4748 Young-Eun Kim https://orcid.org/0000-0003-3327-2515 So Min Lee https://orcid.org/0000-0003-3833-6792 Epidemiology of seasonal and perennial rhinitis:clinicalpresentationandmedicalhistory Rhinitisanditsimpacton work Economicburdenofrhinitisinmanagedcare:aretrospectiveclaimsdataanalysis Aliteraturestudyoftopicalapplication ofchineseherbalmedicineforallergicrhinitis A survey on treatment trend for allergic rhinitis in korean medicine clinic Zhouhoubeijifang(Handbook of Prescriptions for Emergencies) Seoul,Korea:Younglimsa Quantitativeanalysisof anti-inflammatory activity of orengedokuto: importance of combination of flavonoids in inhibition of PGE2 production in mouse macrophage-likecelllineJ774.1 Du-Tangexertsanti-inflammatoryeffectsinratsthroughinhibitionofnitricoxideproduction and eicosanoid biosynthesis via the lipoxygenase pathway TheeffectsofHwanryunhaedoktang pharmacopuncture by the anti-inflammatory action of su-presssionofiNOSproductiononmicewithallergicrhinitis Inhibition of immunoglobulin E-mediated anaphylaxis by modified Hwanglyunhaedoktang AStudyonthedevelopmentofguidelineforassessinganteriornasalcavityusingnasalendoscopyonallergicrhinitispatients Influences of nasal lavage collection-, processing-and storage methods on inflammatory markers-evaluationofamethodfornon-invasivesamplingofepithelialliningfluidincysticfibrosisandotherrespiratorydiseases Simultaneousquantificationofsix humancytokinesinasinglesampleusingmicroparticle-basedflow cytometrictechnology The role of cytokineInterleukin-2,transcriptionfactorofFoxP3intheimmu-nologicalregulationofallergicrhinitis Association ofinterleukin-8andneutrophilswithnasalsymptomseverityduring acuterespiratoryinfection MIG (CXCL9),IP-10(CXCL10)andI-TAC(CXCL11)concentrationsafter nasalallergenchallengeinpatientswithallergicrhinitis TranscriptionandtranslationofthechemokinesRANTES andMCP-1innasalpolypsandmucosainallergicandnon-allergic rhinopathies Seasonalpat-ternsofrespiratorysyncytialvirusinfectioninHongKong:apreliminaryreport Rhinitis subtypes, endotypes, and definitions